WIPOSchützen Sie diese Marke vor Nachahmern!
Mit unserer Markenüberwachung werden Sie automatisch per E-Mail über Nachahmer und Trittbrettfahrer benachrichtigt.
Die Internationale Marke SCRIBE wurde als Wortmarke am 07.05.2019 bei der Weltorganisation für geistiges Eigentum angemeldet.
| Markenform | Wortmarke |
| Aktenzeichen | 1483276 |
| Länder | 
|
| Basismarke |
Nr. 88188800,
09. November 2018
|
| Anmeldedatum | 07. Mai 2019 |
| Ablaufdatum | 07. Mai 2029 |
Markeninhaber
1150 Marina Village Parkway
Alameda CA 94501
US
Alameda CA 94501
US
Markenvertreter
1299 Pennsylvania Avenue, NW,
Suite 700
US
Waren und Dienstleistungen
05
Pharmaceutical and biological preparations based on genetic
engineering and gene therapy for use in diagnosis,
prevention, and treatment of diseases in human therapeutics;
gene therapy products, namely, biological preparations based
on engineered cells for medical use in immuno oncology,
degenerative disorders, traumatic injury, enzyme replacement
therapy, and immunology; pharmaceutical and biological
preparations based on gene, genome, and cellular editing,
modulation, and modification for use in human therapeutics;
pharmaceutical preparations, namely, therapeutic
pharmaceuticals developed through genome modifications for
the prevention and treatment of genomic disorders, including
neurological disorders, Huntington's disease, amyotrophic
lateral sclerosis (ALS), front temporal dementia, pain,
Alzheimer's, Parkinson's, ataxia, autism, epilepsy, pain,
and also including cardiovascular, peripheral nervous
system, cancer, endocrine, gastrointestinal, renal, genetic
immunological, hepatic, infectious, inflammatory, metabolic,
autoimmune, musculoskeletal, neurological, ophthalmological,
respiratory, urogenital, urological, hematologic and viral
or bacterial diseases and disorders
42
Scientific and medical research in the fields of genome
editing, gene editing, genome engineering, gene modulation,
transcriptional regulation, transcriptional modulation,
genetic diseases, gene therapy and cell therapy, and genetic
engineering research and development of pharmaceuticals,
biological preparations, diagnostic and therapeutic products
and services; design and development of engineered cells for
use in scientific research and drug discovery and
development; providing medical research and scientific
research information in the fields of genome editing, gene
editing, genome engineering, gene modulation,
transcriptional regulation, transcriptional modulation,
genetic diseases, gene therapy and cell therapy, and genetic
engineering; molecular diagnostic services for medical
research purposes
44
Molecular diagnostic services for medical purposes; medical
diagnostic testing services in the field of human disease
and human medical conditions
Die Bezeichnungen wurden automatisch übersetzt. Übersetzung anzeigen
Markenhistorie
| Datum | Belegnummer | Bereich | Eintrag |
|---|---|---|---|
| 03. November 2022 | 2023/1 Gaz | US | RAW: Partial Ceasing Effect |
| 14. Februar 2020 | 2020/7 Gaz | AU | Ablehnung |
| 13. Februar 2020 | 2020/7 Gaz | GB | Ablehnung |
| 24. Januar 2020 | 2020/5 Gaz | EM | Ablehnung |
| 07. Mai 2019 | 2019/32 Gaz | US | Eintragung |
ID: 141483276